Your brain runs a 24/7 recycling operation that would make any sustainability officer weep with joy. Every time a neuron fires off a burst of dopamine - the chemical messenger behind motivation, movement, and that little thrill when your food delivery arrives early - a molecular vacuum cleaner called the dopamine transporter (DAT) sucks it right back up. Efficient. Elegant. Absolutely essential.

Now imagine the vacuum breaks. Dopamine just... puddles everywhere. You'd think a dopamine surplus would feel amazing, but the brain is not that simple. A team led by Freja Herborg at the University of Copenhagen just built a mouse that shows, in excruciating detail, exactly how a busted dopamine vacuum can give you Parkinson's-like symptoms AND ADHD at the same time (Herborg et al., 2026). Because the brain loves a good contradiction.

One Gene, Two Mutations, Zero Chill

The backstory here starts with a real patient - a man who developed Parkinson's-like tremors in his late twenties and was diagnosed with ADHD at 39. Genetic testing revealed he'd inherited two different mutations in his DAT gene (SLC6A3), one from each parent: I312F (which cuts dopamine-vacuuming power roughly in half) and D421N (which basically unplugs the vacuum entirely). This one-two punch is what doctors call a compound heterozygote, and it's the genetic setup behind "atypical" Dopamine Transporter Deficiency Syndrome, or DTDS.

DTDS is ultra-rare - fewer than 60 cases documented worldwide (Ng et al., 2014). In its classic form, babies develop devastating movement problems within months. But the atypical version is sneakier: normal development at first, then ADHD in childhood, followed by parkinsonian features creeping in later (Ng et al., 2023). So: one gene, a spectrum of misery, and until now, very little understanding of what's actually going wrong under the hood.

A Mouse Built From a Patient's Genetic Typo

Rather than just deleting the DAT gene entirely (which has been done before and produces mice so hyperactive they make caffeinated squirrels look chill), the Copenhagen team did something smarter. They engineered mice carrying the exact same two mutations from that patient - DAT-I312F on one chromosome, D421N on the other. Letter for letter, the same genetic typo.

What they found was a neurochemical domino collapse:

• DAT function slashed by ~75%, so dopamine was pooling in synapses like water in a clogged drain
• Extracellular dopamine shot up nearly 3-fold - the brain was swimming in the stuff
• Tyrosine hydroxylase (the enzyme that manufactures dopamine) cut its own production by ~45%, like a factory slowing the assembly line because the warehouse is overflowing
• D1 and D2 receptors - the docking stations where dopamine actually does its work - dialed down their numbers, neurons essentially hanging "Do Not Disturb" signs
• Evoked dopamine release cratered by over 80%, because overactive D2 autoreceptors (think: a stuck thermostat that always reads "too hot") kept telling neurons to stop releasing dopamine even when the brain desperately needed it

The brain, in trying to cope with a dopamine flood, accidentally made itself dopamine-deaf.

Hyperactive, Clasping, and Thoroughly Confused

Behaviorally, these mice were a walking (well, sprinting) contradiction. They were hyperactive, explored everything in sight, and displayed "pronounced clasping" - a neurological red flag in rodents that maps onto the dystonia and motor dysfunction seen in human patients. They were lighter, had hunched spines, and basically refused to sit still.

But here's what made the fiber photometry data really wild. When the researchers measured real-time dopamine dynamics in the striatum, normal mice showed crisp, snappy bursts of dopamine - sharp signals encoding specific information, like Morse code. The mutant mice? Slow, rolling, irregular waves. Their dopamine signaling looked less like a communication system and more like a lava lamp. Technically still moving, but not actually saying anything useful.

The Amphetamine Plot Twist (and Why It Matters for ADHD)

If you give a normal mouse amphetamine, it goes bananas - running, exploring, generally acting like it just discovered it has legs. Give the same dose to these DAT-mutant mice? They calmed down. The hyperactivity dropped. This is the exact same paradoxical response seen in human ADHD patients taking stimulant medications like Adderall, and it's been one of the great "wait, that shouldn't work" puzzles in psychiatry for decades.

The researchers cracked the "why" with microdialysis experiments. Amphetamine-triggered dopamine release was virtually obliterated in the ventral striatum - the brain's reward and motivation hub - but largely preserved in the dorsal striatum, which handles motor control. This regional split is potentially a game-changer: it means the same genetic defect can wreck the reward circuit (hello, ADHD) while leaving the motor circuit partially functional (slower-onset parkinsonism), explaining how one broken protein produces two seemingly opposite diseases.

Anticholinergic drugs also tamed the hyperactivity, aligning with current treatment strategies for dystonia in DTDS patients and offering a second therapeutic angle.

Beyond the Mouse Cage

DTDS is rare, but the lessons here ripple outward. The overlap between movement disorders and psychiatric conditions - Parkinson's patients who develop depression, ADHD patients with motor coordination problems - is one of neurology's big unsolved puzzles. This mouse model provides a clean, controlled system where researchers can watch that overlap unfold in real time.

The findings also reshape how we think about treatment. If amphetamine's calming effect is region-specific, the goal isn't blasting the whole brain with more or less dopamine. It's fine-tuning specific circuits. That's a fundamentally different approach to drug development. Meanwhile, gene therapy trials using viral vectors to deliver functional DAT copies are already moving toward clinical trials in the UK for DTDS patients (Ng et al., 2023), and models like this one will be essential for testing next-generation treatments.

Your dopamine system isn't an on/off switch. It's a finely tuned orchestra where the transporter, the receptors, the enzymes, and the regional wiring all have to harmonize. Knock one instrument out of tune - the DAT vacuum - and the whole concert falls apart in ways nobody predicted. These mice just let us hear every off-key note.

References:

1. Herborg, F., Konrad, L.K., Jørgensen, S.H., et al. (2026). Mouse model of atypical DAT deficiency syndrome uncovers dopamine dysfunction associated with parkinsonism and ADHD. The Journal of Clinical Investigation. DOI: 10.1172/JCI169297. PMID: 41591817

2. Ng, J., Zhen, J., Meyer, E., et al. (2014). Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood. Brain, 137(4), 1107-1119. DOI: 10.1093/brain/awu022. PMID: 24613933

3. Ng, J., Barral, S., Waddington, S.N., et al. (2023). Dopamine Transporter Deficiency Syndrome (DTDS): Expanding the Clinical Phenotype and Precision Medicine Approaches. Cells, 12(13), 1737. DOI: 10.3390/cells12131737. PMCID: PMC10341083

4. Bhatt, M., Shilling, P.D., Bhatt, S., et al. (2023). The dopamine transporter gene SLC6A3: multidisease risks. Molecular Psychiatry, 28, 1-8. DOI: 10.1038/s41380-021-01341-5. PMID: 34750558

5. Hansen, F.H., Skjørringe, T., Bhatt, P., et al. (2014). Missense dopamine transporter mutations associate with adult parkinsonism and ADHD. The Journal of Clinical Investigation, 124(7), 3107-3120. DOI: 10.1172/JCI73778. PMCID: PMC4071392

Disclaimer: The image accompanying this article is for illustrative purposes only and does not depict actual experimental results, data, or biological mechanisms.